Endoglin (CD105) as a novel serum marker for hepatocellular carcinoma in Egyptian patients with chronic liver disease

Mohga A. Reda; Mohamed O. Khalifa; Yasser Elhosary; Dina Kandil; Ahmed Emara

doi:10.1097/01.elx.0000429699.41933.e1

Citations

388

Views

Abstract not available for this publication.

Cite this Article (APA)

Mohga, A. R., Mohamed, O. K., Yasser, E., Dina, K., Ahmed, E. (2013). Endoglin (CD105) as a novel serum marker for hepatocellular carcinoma in Egyptian patients with chronic liver disease. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000429699.41933.e1

Gamal Shiha; Seham Seif; Maha Maher; Shahera Etreby; Waleed Samir; Khaled Zalata · 2014

cites

389

Tissue microarray as a research tool to study non-neoplastic liver diseases

Mohamed H. Abdel-Rahman; Ahmad A. Agour; Dina S. El-Azab · 2014

cites

388

Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt

Iman I. Sarhan; Cherry R. Kamel · 2015

cites

391

Prevention of paracentesis-induced circulatory dysfunction